middle.news
Vectus Biosystems Trades Renal Drug for US$3M Stake in XORTX
7:01am on Saturday 18th of October, 2025 AEDT
•
Healthcare
Read Story
Vectus Biosystems Trades Renal Drug for US$3M Stake in XORTX
7:01am on Saturday 18th of October, 2025 AEDT
Key Points
Sale of VB4-P5 renal fibrosis compound to XORTX for US$3 million
Consideration paid via shares and pre-funded warrants in XORTX
Vectus gains direct equity stake in Nasdaq- and TSXV-listed XORTX
Transaction subject to closing conditions and possible ASX approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vectus Biosystems (ASX:VBS)
OPEN ARTICLE